As of 2026-06-08, the Relative Valuation of Inozyme Pharma Inc (INZY) is (26.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -771.5%.
The range of the Relative Valuation is (24.96) - (28.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.4x | 16.2x |
| Forward P/E multiples | 13.1x - 19.4x | 16.2x |
| Fair Price | (24.96) - (28.76) | (26.86) |
| Upside | -724.0% - -819.0% | -771.5% |
| Date | P/E |